Cardiovascular disease in sub-Saharan Africa: a disaster waiting to happen

M A B van der Sande1

  • 1MRC Laboratories, PO Box 274, Banjul, The Gambia. mvdsande@mrc.gm

Insights

Cardiovascular disease (CVD) is a growing, underestimated threat in sub-Saharan Africa (sSA). Urgent preventive measures are needed to address rising risk factors and the

Area of Science:

  • Public Health
  • Epidemiology
  • Global Health

Background:

  • Cardiovascular disease (CVD) emergence in sub-Saharan Africa (sSA) is a significant and underestimated public health challenge.
  • Existing health systems in sSA are overburdened by poverty, conflict, and the HIV/AIDS epidemic, diverting attention from non-communicable diseases like CVD.
  • Limited reliable data on CVD prevalence and risk factors in sSA contribute to its neglect.

Purpose of the Study:

  • To review the increasing prevalence of CVD risk factors in specific regions of sub-Saharan Africa.
  • To highlight the urgent need for preventive strategies to combat the escalating burden of CVD in the region.
  • To underscore the necessity of addressing the 'double burden of disease' (communicable and non-communicable diseases) in sSA.

Main Methods:

  • This study is a short review of existing literature and data on cardiovascular disease risk factors in sub-Saharan Africa.
  • Analysis of trends in CVD risk factors in specific geographical areas within sSA.
  • Synthesis of information to identify neglected warning signs of CVD emergence.

Main Results:

  • Evidence indicates a significant increase in cardiovascular disease risk factors in certain areas of sub-Saharan Africa.
  • The underestimation and denial of CVD as a threat in sSA are linked to a lack of comprehensive data and competing health priorities.
  • Warning signs of CVD emergence are being overlooked due to the focus on infectious diseases and socioeconomic challenges.

Conclusions:

  • Cardiovascular disease poses a serious and growing threat to sub-Saharan Africa that requires immediate attention.
  • Preventive measures are crucial to mitigate the rising incidence of CVD and its associated risk factors.
  • Addressing the 'double burden of disease' necessitates integrating CVD prevention and management into the broader health strategies of sub-Saharan Africa.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...